Vimarsana
Biggest News Aggregation in the World

Abbott Flexnav News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abbott Flexnav. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abbott Flexnav Today - Breaking & Trending Today

Abbott Receives FDA Approval for Navitor TAVI System - Vimarsana News

Abbott Receives FDA Approval for Navitor TAVI System

Abbott's new Navitor device features advancements to improve patient care, including reducing or eliminating risk of blood leakage around valve implant

Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis - Vimarsana News

Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's latest-generation transcatheter aortic valve implantation

Abbott wins FDA nod for Navitor transcatheter aortic valve implant - Vimarsana News

Abbott wins FDA nod for Navitor transcatheter aortic valve implant

Abbott (NYSE:ABT) announced today that it received FDA approval for its latest-generation transcatheter aortic valve implant (TAVI) system.

Abbott has received the CE Mark for Navitor - Vimarsana News

Abbott has received the CE Mark for Navitor

Abbott has announced it has received the CE Mark for its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor™, making the minimally invasive device available for people in Europe with severe aortic stenosis who are at high or extreme surgical risk. 

Abbott Receives CE Mark for Navitor, the Latest-Generation Transcatheter Aortic Valve Implantation System to Treat Aortic Stenosis - Vimarsana News

Abbott Receives CE Mark for Navitor, the Latest-Generation Transcatheter Aortic Valve Implantation System to Treat Aortic Stenosis

Abbott  today announced it has received CE Mark for its latest-generation transcatheter aortic valve implantation system, Navitor™, making the minimally invasive device available for people in Europe with severe aortic stenosis who are at high or extreme surgical risk. With the Navitor valve, the company is advancing TAVI therapies with innovations including a unique design to prevent blood leaking around the … Abbott (NYSE: ABT) today announced it has received CE Mark for its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor™, making the minimally invas...